U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07430722) titled 'Cross-sectional Study of Vitamin B6 in Parkinson's Disease' on Feb. 17.
Brief Summary: The purpose of this study is to estimate the prevalence of abnormal serum levels of vitamin B6, and the associations of those levels with demographic and clinical variables in a randomly selected sample of people living with Parkinson's disease, compared to historical controls.
Study Start Date: July 01, 2024
Study Type: OBSERVATIONAL
Condition:
Parkinson's Disease (PD)
Recruitment Status: COMPLETED
Sponsor: University of Rochester
Information provided by (Responsible Party): Karlo Lizarraga, University of Rochester
Published by HT Digital...